Literature DB >> 12871755

Antiulcerogenic effect and cytotoxic activity of semi-synthetic crotonin obtained from Croton cajucara Benth.

Ana Beatriz Albino de Almeida1, Patricia S Melo, Clelia A Hiruma-Lima, Juliano S Gracioso, Ligia Carli, Domingos S Nunes, Marcela Haun, Alba R M Souza Brito.   

Abstract

Trans-dehydrocrotonin, the major diterpene isolated from the bark of Croton cajucara, has good antiulcerogenic activity which, however, is accompanied by toxic effects. On the basis of these results, a semi-synthetic crotonin, named 4SRC, was prepared to determine whether this substance has similar antiulcerogenic activity with lower or no toxicity. The natural crotonin was also isolated from the bark of C. cajucara but was not used due to the small amount obtained. The cytotoxic effect of semi-synthetic crotonin, expressed as cell viability, was assessed in (a) lung fibroblast cell line (V79) derived from Chinese hamsters, a system commonly used for cytotoxicity studies, and (b) rat hepatocytes isolated from male Wistar rats. After treatment, cell viability was determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide reduction (MTT reduction), total acid content and neutral red uptake assays. To evaluate V79 cell viability, different concentrations of semi-synthetic crotonin were incubated with the cells. To evaluate the antiulcerogenic effects of semi-synthetic crotonin (50, 100 and 200 mg/kg), we used the models of gastric ulcer induced by ethanol/HCl, stress, indomethacin/bethanechol, and ethanol in male Swiss mice and male Wistar rats. The substance had an IC(50)=500 microM in the neutral red uptake and MTT reduction tests and an IC(50)=200 microM in the nucleic acid content test. With regard to hepatocyte viability after treatment with semi-synthetic crotonin at different concentrations, semi-synthetic crotonin had an IC(50)=10-500 microM in the nucleic acid content and MTT reduction tests and an IC(50)=120 microM in the neutral red uptake test. In another experiment, V79 cells were incubated with the metabolites produced by hepatocytes treated with different concentrations of semi-synthetic crotonin. After a 4-h incubation, semi-synthetic crotonin had an IC(50)=500 microM in the MTT reduction and neutral red uptake tests and an IC(50)=370 microM in nucleic acid content test. The substance had significant antiulcerogenic activity in all models studied, suggesting the presence of a possible antisecretory effect combined with a cytoprotective effect. For this reason, the effect of semi-synthetic crotonin was also evaluated on biochemical parameters of gastric juice and gastric wall mucus, both obtained from pylorus-ligated mice. No significant differences were observed in these parameters between semi-synthetic crotonin-treated and control animals. The results obtained with semi-synthetic crotonin are promising, with a significant preventive effect against gastric ulcer induced by different agents. Our data also show that semi-synthetic crotonin was less toxic than dehydrocrotonin and that the cytotoxic effects decreases with the time that isolated hepatocytes were in culture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871755     DOI: 10.1016/s0014-2999(03)01909-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  The gastroprotective effect of ethyl acetate fraction of hot water extract of Trichosanthes cucumerina Linn and its underlying mechanisms.

Authors:  Ramani Karunakaran; M Ira Thabrew; G Mayuri Thammitiyagodage; B Prasanna Galhena; L D A Menuka Arawwawala
Journal:  BMC Complement Altern Med       Date:  2017-06-14       Impact factor: 3.659

2.  Antiulcerogenic Activity of the Hydroalcoholic Extract of Leaves of Croton campestris A. St.-Hill in Rodents.

Authors:  Francisco E B Júnior; Dayanne R de Oliveira; Elizângela B Bento; Laura H I Leite; Daniele O Souza; Ana Luiza A Siebra; Renata S Sampaio; Anita O P B Martins; Andreza G B Ramos; Saulo R Tintino; Luiz J Lacerda-Neto; Patricia R L Figueiredo; Larissa R Oliveira; Cristina K S Rodrigues; Valterlúcio S Sales; Francisco R S D N Figueiredo; Emmily P Nascimento; Alefe B Monteiro; Erika N Amaro; José G M Costa; Henrique Douglas Melo Coutinho; Irwin R A de Menezes; Marta R Kerntopf
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-20       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.